Literature DB >> 27380142

Caldoramide, a Modified Pentapeptide from the Marine Cyanobacterium Caldora penicillata.

Sarath P Gunasekera1, Lorelie Imperial, Christiana Garst1, Ranjala Ratnayake, Long H Dang, Valerie J Paul1, Hendrik Luesch.   

Abstract

The isolation, structure determination, and biological activities of a new linear pentapeptide, caldoramide (5), from the marine cyanobacterium n class="Species">Caldora penicillata from Florida are described. Caldoramide (5) has structural similarities to belamide A (4), dolastatin 10 (1), and dolastatin 15 (2). We profiled caldoramide against parental HCT116 colorectal cancer cells and isogenic cells lacking oncogenic KRAS or hypoxia-inducible factors 1α (HIF-1α) and 2α (HIF-2α). Caldoramide (5) showed differential cytotoxicity for cells containing both oncogenic KRAS and HIF over the corresponding knockout cells. LCMS dereplication indicated the presence of caldoramide (5) in a subset of C. penicillata samples.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27380142      PMCID: PMC5215049          DOI: 10.1021/acs.jnatprod.6b00203

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  13 in total

1.  The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages.

Authors:  K L Talks; H Turley; K C Gatter; P H Maxwell; C W Pugh; P J Ratcliffe; A L Harris
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 2.  Biogenetic diversity of cyanobacterial metabolites.

Authors:  Ryan M Van Wagoner; Allison K Drummond; Jeffrey L C Wright
Journal:  Adv Appl Microbiol       Date:  2007       Impact factor: 5.086

3.  Structure and activity of largazole, a potent antiproliferative agent from the Floridian marine cyanobacterium Symploca sp.

Authors:  Kanchan Taori; Valerie J Paul; Hendrik Luesch
Journal:  J Am Chem Soc       Date:  2008-01-19       Impact factor: 15.419

Review 4.  Marine natural products.

Authors:  John W Blunt; Brent R Copp; Robert A Keyzers; Murray H G Munro; Michèle R Prinsep
Journal:  Nat Prod Rep       Date:  2014-01-17       Impact factor: 13.423

5.  Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1.

Authors:  H Luesch; R E Moore; V J Paul; S L Mooberry; T H Corbett
Journal:  J Nat Prod       Date:  2001-07       Impact factor: 4.050

6.  The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma.

Authors:  Peter D Senter; Eric L Sievers
Journal:  Nat Biotechnol       Date:  2012-07-10       Impact factor: 54.908

Review 7.  Bioactive natural products from marine cyanobacteria for drug discovery.

Authors:  Lik Tong Tan
Journal:  Phytochemistry       Date:  2007-03-02       Impact factor: 4.072

8.  Caldora penicillata gen. nov., comb. nov. (cyanobacteria), a pantropical marine species with biomedical relevance.

Authors:  Niclas Engene; Ana Tronholm; Lilibeth A Salvador-Reyes; Hendrik Luesch; Valerie J Paul
Journal:  J Phycol       Date:  2015-08       Impact factor: 2.923

9.  Multidimensional Screening Platform for Simultaneously Targeting Oncogenic KRAS and Hypoxia-Inducible Factors Pathways in Colorectal Cancer.

Authors:  Michelle S Bousquet; Jia Jia Ma; Ranjala Ratnayake; Pamela A Havre; Jin Yao; Nam H Dang; Valerie J Paul; Thomas J Carney; Long H Dang; Hendrik Luesch
Journal:  ACS Chem Biol       Date:  2016-03-03       Impact factor: 5.100

10.  Targeting both HIF-1 and HIF-2 in human colon cancer cells improves tumor response to sunitinib treatment.

Authors:  Kyunghee Burkitt; Sang Y Chun; Duyen T Dang; Long H Dang
Journal:  Mol Cancer Ther       Date:  2009-05-12       Impact factor: 6.261

View more
  6 in total

Review 1.  Marine natural product peptides with therapeutic potential: Chemistry, biosynthesis, and pharmacology.

Authors:  Vedanjali Gogineni; Mark T Hamann
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-08-24       Impact factor: 3.770

2.  Inhibition of the HIF-1 Survival Pathway as a Strategy to Augment Photodynamic Therapy Efficacy.

Authors:  Mark J de Keijzer; Daniel J de Klerk; Lianne R de Haan; Robert T van Kooten; Leonardo P Franchi; Lionel M Dias; Tony G Kleijn; Diederick J van Doorn; Michal Heger
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Structural Diversity, Biological Properties and Applications of Natural Products from Cyanobacteria. A Review.

Authors:  Sayed Asmat Ali Shah; Najeeb Akhter; Bibi Nazia Auckloo; Ishrat Khan; Yanbin Lu; Kuiwu Wang; Bin Wu; Yue-Wei Guo
Journal:  Mar Drugs       Date:  2017-11-10       Impact factor: 5.118

Review 4.  New Peptides Isolated from Marine Cyanobacteria, an Overview over the Past Decade.

Authors:  Yue Mi; Jinrong Zhang; Shan He; Xiaojun Yan
Journal:  Mar Drugs       Date:  2017-05-05       Impact factor: 5.118

Review 5.  The Biological and Chemical Diversity of Tetramic Acid Compounds from Marine-Derived Microorganisms.

Authors:  Minghua Jiang; Senhua Chen; Jing Li; Lan Liu
Journal:  Mar Drugs       Date:  2020-02-15       Impact factor: 5.118

6.  Genome Reduction and Secondary Metabolism of the Marine Sponge-Associated Cyanobacterium Leptothoe.

Authors:  Despoina Konstantinou; Rafael V Popin; David P Fewer; Kaarina Sivonen; Spyros Gkelis
Journal:  Mar Drugs       Date:  2021-05-24       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.